X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11021) 11021
Publication (983) 983
Book Review (129) 129
Book / eBook (76) 76
Magazine Article (75) 75
Book Chapter (55) 55
Newsletter (30) 30
Conference Proceeding (13) 13
Dissertation (8) 8
Trade Publication Article (7) 7
Paper (5) 5
Data Set (3) 3
Report (3) 3
Newspaper Article (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10155) 10155
male (5760) 5760
female (5481) 5481
adult (5138) 5138
aids-related opportunistic infections - epidemiology (4216) 4216
middle aged (3424) 3424
index medicus (3322) 3322
infectious diseases (2983) 2983
risk factors (2566) 2566
hiv (2404) 2404
aids (2379) 2379
adolescent (1935) 1935
incidence (1775) 1775
immunology (1716) 1716
hiv infections - complications (1677) 1677
prevalence (1657) 1657
epidemiology (1616) 1616
aged (1614) 1614
aids-related opportunistic infections - diagnosis (1497) 1497
tuberculosis (1483) 1483
microbiology (1466) 1466
aids-related opportunistic infections - drug therapy (1461) 1461
child (1422) 1422
retrospective studies (1416) 1416
infections (1382) 1382
hiv infections - epidemiology (1355) 1355
infection (1254) 1254
opportunistic infections - epidemiology (1233) 1233
opportunistic infections (1200) 1200
human-immunodeficiency-virus (1196) 1196
health aspects (1162) 1162
hiv infections - drug therapy (1141) 1141
cd4 lymphocyte count (1139) 1139
aids-related opportunistic infections - microbiology (1118) 1118
mortality (1091) 1091
hiv infection (1027) 1027
child, preschool (960) 960
tuberculosis - epidemiology (929) 929
diagnosis (899) 899
aids-related opportunistic infections - prevention & control (889) 889
animals (870) 870
infant (840) 840
aids-related opportunistic infections - complications (834) 834
medicine, general & internal (821) 821
prospective studies (805) 805
immunocompromised host (792) 792
young adult (790) 790
disease (786) 786
research (746) 746
treatment outcome (743) 743
cohort studies (713) 713
acquired immunodeficiency syndrome - complications (708) 708
public, environmental & occupational health (700) 700
human immunodeficiency virus--hiv (699) 699
research article (691) 691
antiretroviral therapy, highly active (679) 679
care and treatment (670) 670
aids-related opportunistic infections - mortality (668) 668
opportunist infection (651) 651
acquired immunodeficiency syndrome - epidemiology (642) 642
cross-sectional studies (639) 639
antiretroviral therapy (632) 632
medicine (627) 627
hiv-1 (619) 619
hiv patients (608) 608
aids-related opportunistic infections - immunology (606) 606
human immunodeficiency virus (600) 600
active antiretroviral therapy (592) 592
tuberculosis, pulmonary - epidemiology (580) 580
anti-hiv agents - therapeutic use (573) 573
therapy (572) 572
opportunistic infections - microbiology (556) 556
opportunistic infections - complications (548) 548
antitubercular agents - therapeutic use (542) 542
virology (541) 541
respiratory system (534) 534
antifungal agents - therapeutic use (517) 517
risk-factors (514) 514
analysis (509) 509
prognosis (509) 509
risk (480) 480
united states - epidemiology (479) 479
opportunistic infections - diagnosis (477) 477
highly active antiretroviral therapy (475) 475
drug therapy (474) 474
hiv infections - immunology (472) 472
comorbidity (464) 464
pathogens (464) 464
pneumonia (456) 456
acquired immune deficiency syndrome--aids (454) 454
follow-up studies (440) 440
acquired-immunodeficiency-syndrome (438) 438
patients (438) 438
prevention (437) 437
children (431) 431
time factors (428) 428
antiviral agents (417) 417
multidisciplinary sciences (417) 417
aged, 80 and over (415) 415
tropical medicine (412) 412
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - General (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10004) 10004
French (355) 355
Spanish (342) 342
German (199) 199
Russian (71) 71
Portuguese (61) 61
Japanese (41) 41
Polish (40) 40
Italian (36) 36
Dutch (27) 27
Romanian (16) 16
Turkish (14) 14
Danish (12) 12
Norwegian (12) 12
Chinese (11) 11
Hungarian (9) 9
Korean (5) 5
Swedish (5) 5
Finnish (3) 3
Hebrew (3) 3
Croatian (2) 2
Bulgarian (1) 1
Lithuanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 06/2006, Volume 118, Issue 12, pp. 3030 - 3044
Several infectious agents are considered to be causes of cancer in humans. The fraction of the different types of cancer, and of all cancers worldwide and in... 
attributable fraction | infection | cancer | estimates | Infection | Attributable fraction | Estimates | Cancer | ACQUIRED-IMMUNODEFICIENCY-SYNDROME | HUMAN-PAPILLOMAVIRUS TYPE-16 | SARCOMA-ASSOCIATED HERPESVIRUS | T-CELL LEUKEMIA | RANDOMIZED CONTROLLED-TRIAL | HEPATITIS-C VIRUS | ONCOLOGY | HELICOBACTER-PYLORI INFECTION | NON-HODGKINS-LYMPHOMA | INVASIVE CERVICAL-CANCER | EPSTEIN-BARR-VIRUS | Africa - epidemiology | Neoplasms - parasitology | Prevalence | Schistosoma haematobium | Cholangiocarcinoma - parasitology | Developing Countries - statistics & numerical data | Humans | Helicobacter Infections - complications | Hepatitis B - epidemiology | Infection - virology | Developed Countries - statistics & numerical data | Hepatitis B - complications | Americas - epidemiology | Neoplasms - virology | Infection - epidemiology | Helicobacter pylori | Hepatitis C - epidemiology | Hepatitis C - complications | Stomach Neoplasms - epidemiology | Sarcoma, Kaposi - epidemiology | Lymphoma - epidemiology | Papillomavirus Infections - complications | Global Health | Cholangiocarcinoma - epidemiology | Neoplasms - microbiology | Infection - microbiology | Opisthorchiasis - complications | Schistosomiasis - complications | Tumor Virus Infections - complications | Stomach Neoplasms - microbiology | Asia - epidemiology | Animals | AIDS-Related Opportunistic Infections - epidemiology | Epstein-Barr Virus Infections - complications | Papillomaviridae | Infection - parasitology | Opisthorchis | Infection - complications | Neoplasms - epidemiology | Lymphoma - virology
Journal Article
Journal Article
Veterinary Microbiology, ISSN 0378-1135, 02/2017, Volume 200, pp. 71 - 78
Although the problems associated with healthcare-associated infections (HAI) and the emergence of zoonotic and multidrug-resistant pathogens in companion... 
Companion animals | Healthcare-associated infection | Nosocomial | MRSP | MRSA | ESBL | Public health | Infection control | RISK-FACTORS | PUBLIC-HEALTH | ESCHERICHIA-COLI | MICROBIOLOGY | TO-DOG TRANSMISSION | ANTIMICROBIAL RESISTANCE | NOSOCOMIAL INFECTIONS | SALMONELLA-TYPHIMURIUM | STAPHYLOCOCCUS-AUREUS MRSA | VETERINARY SCIENCES | KLEBSIELLA-PNEUMONIAE | Dog Diseases - epidemiology | Escherichia coli Infections - prevention & control | Escherichia coli - drug effects | Humans | Dog Diseases - microbiology | Hospitals, Animal | Opportunistic Infections - prevention & control | Staphylococcal Infections - veterinary | Cat Diseases - prevention & control | Horse Diseases - epidemiology | Salmonella Infections, Animal - prevention & control | Drug Resistance, Multiple, Bacterial | Horse Diseases - prevention & control | Cat Diseases - epidemiology | Escherichia coli Infections - veterinary | Staphylococcal Infections - microbiology | Dog Diseases - prevention & control | Cats | Opportunistic Infections - epidemiology | Methicillin-Resistant Staphylococcus aureus - drug effects | Escherichia coli Infections - microbiology | Salmonella - drug effects | Staphylococcus - drug effects | Salmonella Infections, Animal - epidemiology | Opportunistic Infections - microbiology | Cat Diseases - microbiology | Escherichia coli Infections - epidemiology | Pets | Animals | Staphylococcal Infections - epidemiology | Cross Infection - veterinary | Dogs | Salmonella Infections, Animal - microbiology | Horses | Staphylococcal Infections - prevention & control | Anti-Bacterial Agents - pharmacology | Horse Diseases - microbiology | Drug resistance in microorganisms | Beta lactamases | Pathogenic microorganisms | Health aspects | Wildlife conservation | Staphylococcal infections | Escherichia coli
Journal Article
Gut, ISSN 0017-5749, 05/2017, Volume 66, Issue 5, pp. 839 - 851
ObjectiveVedolizumab is a gut-selective antibody to α4β7 integrin for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). We report an... 
INFLAMMATORY-BOWEL-DISEASE | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | OPPORTUNISTIC INFECTIONS | FOLLOW-UP | RISK | EXPERIENCE | COHORT | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | ADVERSE EVENTS | MAINTENANCE THERAPY | Tuberculosis - epidemiology | Age Factors | Humans | Middle Aged | Male | Narcotics - therapeutic use | Clostridium Infections - epidemiology | Adrenal Cortex Hormones - therapeutic use | Incidence | Young Adult | Treatment Failure | Infusions, Intravenous - adverse effects | Gastrointestinal Agents - immunology | Adult | Female | Colitis, Ulcerative - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Sepsis - epidemiology | Chemical and Drug Induced Liver Injury - epidemiology | Randomized Controlled Trials as Topic | Crohn Disease - drug therapy | Gastrointestinal Agents - therapeutic use | Gastrointestinal Agents - adverse effects | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Neutralizing - blood | Leukoencephalopathy, Progressive Multifocal - epidemiology | Neoplasms - epidemiology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Drug therapy | Crohn's disease | Ulcerative colitis | Clinical trials | Infections | Malignancy | Patients | Risk factors | Crohns disease | Inflammatory bowel disease | Studies | Tuberculosis | Tumor necrosis factor | Population | Tumor necrosis factor-TNF | TNF inhibitors | Sepsis | Safety | Drug dosages | Tumors | 1506 | Inflammatory Bowel Disease
Journal Article